Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Carrier

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Pflugers Archiv : European Journal of Physiology|December 17, 2013
MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correctionVerena Behrens-Gawlik, Giulia Mearini, Christina Gedicke-Hornung, et al.
Journal of Muscle Research and Cell Motility|November 8, 2011
How do MYBPC3 mutations cause hypertrophic cardiomyopathy?Steven Marston, O'Neal Copeland, Katja Gehmlich, et al.
Journal of Muscle Research and Cell Motility|November 15, 2011
Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in miceSaskia Schlossarek, Friederike Schuermann, Birgit Geertz, et al.
Biomolecules|November 27, 2021
A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic CardiomyopathyTilo Thottakara, Natalie Lund, Elisabeth Krämer, et al.
Cardiovascular Research|November 14, 2003
Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathyJeanne Flavigny, Philippe Robert, Jean-Claude Camelin, et al.
Basic Research in Cardiology|December 23, 2011
Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophySaskia Schlossarek, Daniel R Englmann, Karim R Sultan, et al.
Seminars in Cell & Developmental Biology|December 20, 2021
The detyrosination/re-tyrosination cycle of tubulin and its role and dysfunction in neurons and cardiomyocytesChadni Sanyal, Niels Pietsch, Sacnicte Ramirez Rios, et al.
Cardiovascular Research|January 21, 2015
Animal and in silico models for the study of sarcomeric cardiomyopathiesDirk J Duncker, Jeroen Bakkers, Bianca J Brundel, et al.
Circulation|August 9, 2006
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillationAli El-Armouche, Peter Boknik, Thomas Eschenhagen, et al.
European Journal of Pharmacology|May 13, 2021
Ouabain worsens diastolic sarcomere length in myocytes from a cardiomyopathy mouse modelSilke Düsener, Frederik Flenner, Christoph Maack, et al.
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Pflugers Archiv : European Journal of Physiology|December 17, 2013
MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correctionVerena Behrens-Gawlik, Giulia Mearini, Christina Gedicke-Hornung, et al.
Journal of Muscle Research and Cell Motility|November 8, 2011
How do MYBPC3 mutations cause hypertrophic cardiomyopathy?Steven Marston, O'Neal Copeland, Katja Gehmlich, et al.
Journal of Muscle Research and Cell Motility|November 15, 2011
Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in miceSaskia Schlossarek, Friederike Schuermann, Birgit Geertz, et al.
Biomolecules|November 27, 2021
A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic CardiomyopathyTilo Thottakara, Natalie Lund, Elisabeth Krämer, et al.
Cardiovascular Research|November 14, 2003
Biomolecular interactions between human recombinant beta-MyHC and cMyBP-Cs implicated in familial hypertrophic cardiomyopathyJeanne Flavigny, Philippe Robert, Jean-Claude Camelin, et al.
Basic Research in Cardiology|December 23, 2011
Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophySaskia Schlossarek, Daniel R Englmann, Karim R Sultan, et al.
Seminars in Cell & Developmental Biology|December 20, 2021
The detyrosination/re-tyrosination cycle of tubulin and its role and dysfunction in neurons and cardiomyocytesChadni Sanyal, Niels Pietsch, Sacnicte Ramirez Rios, et al.
Cardiovascular Research|January 21, 2015
Animal and in silico models for the study of sarcomeric cardiomyopathiesDirk J Duncker, Jeroen Bakkers, Bianca J Brundel, et al.
Circulation|August 9, 2006
Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillationAli El-Armouche, Peter Boknik, Thomas Eschenhagen, et al.
European Journal of Pharmacology|May 13, 2021
Ouabain worsens diastolic sarcomere length in myocytes from a cardiomyopathy mouse modelSilke Düsener, Frederik Flenner, Christoph Maack, et al.
Pageof 15